BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH)

CUSIP: 078771300

Q1 2021 13F Holders as of 31 Mar 2021

Type / Class
Equity / COM NEW
Total 13F shares
2,089,635
Share change
-636,183
Total reported value
$10,846,348
Price per share
$5.19
Number of holders
33
Value change
-$3,399,759
Number of buys
18
Number of sells
14

Quarterly Holders Quick Answers

What is CUSIP 078771300?
CUSIP 078771300 identifies BLPH - BELLEROPHON THERAPEUTICS INC - COM NEW in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Institutional Holders of BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH) as of Q1 2021

As of 31 Mar 2021, BELLEROPHON THERAPEUTICS INC - COM NEW (BLPH) was held by 33 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 2,089,635 shares. The largest 10 holders included VANGUARD GROUP INC, BlackRock Inc., NEW MOUNTAIN VANTAGE ADVISERS, L.L.C., WELLS FARGO & COMPANY/MN, RENAISSANCE TECHNOLOGIES LLC, DAVENPORT & Co LLC, CAAS CAPITAL MANAGEMENT LP, NORTHERN TRUST CORP, GSA CAPITAL PARTNERS LLP, and GEODE CAPITAL MANAGEMENT, LLC. This page lists 33 institutional shareholders reporting positions in this security for the Q1 2021 filing period.
Investor Option Weight % Change % Value $ * Price Shares Share Change Activity Report Period
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.